"Kenvue has world-class brands in attractive categories and a strong global platform. The actions announced today are to ensure we have the right talent, brand portfolio and operational foundation to fully capitalize on those strengths, accelerate profitable growth and best position the Company for future success."
Johnson & Johnson reported it had insufficient evidence to link brain bleeds with the Janssen vaccine, a view that was supported by the European Medicines Agency.